Scientists explored the therapeutic potential of 2-bromo-1,4-naphthalenedione, a derivative of naphthalenedione, in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, and to elucidate its underlying mechanisms.
[Journal of Neuroinflammation]